The systemic inflammation caused by a flu infection is known to increase short-term risk of heart problems, and the flu ...

Influenza vaccination may help protect against heart attack and stroke even when it does not prevent people from getting the ...

Tofacitinib shows safety comparable with biologics for PsA regarding serious infections, myocardial infarction or stroke, and malignancy but is tied to a higher risk for VTE than TNF inhibitors.

Sotagliflozin, a dual SGLT1/2 inhibitor, shows benefit specifically for reducing myocardial infarction and stroke risks. Among patients with type 2 diabetes and chronic kidney disease (CKD) at ...

In Danish adults aged 40 years or older, laboratory-confirmed influenza was linked to a sharp short-term rise in first-time ...

Please provide your email address to receive an email when new articles are posted on . A secondary analysis of the phase 2 PACIFIC-STROKE trial showed that asundexian is effective for the secondary ...

Some patients with an acute large-vessel ischemic stroke who already show a large-core infarct at early imaging can still benefit from thrombectomy, especially if the procedure successfully restores ...

For adults 50 years of age and older with a diagnosis of ASCVD, HZ vaccination is associated with a lower risk for MACE.